Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Return on Assets (2017 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Return on Assets for 9 consecutive years, with 0.4% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 29.0% to 0.4% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.4% through Dec 2025, up 29.0% year-over-year, with the annual reading at 0.45% for FY2025, 27.0% up from the prior year.
  • Return on Assets for Q4 2025 was 0.4% at Rhythm Pharmaceuticals, up from 0.44% in the prior quarter.
  • The five-year high for Return on Assets was 0.14% in Q2 2021, with the low at 0.93% in Q1 2024.
  • Average Return on Assets over 5 years is 0.5%, with a median of 0.52% recorded in 2023.
  • The sharpest move saw Return on Assets tumbled -51bps in 2022, then surged 49bps in 2025.
  • Over 5 years, Return on Assets stood at 0.23% in 2021, then plummeted by -107bps to 0.47% in 2022, then fell by -15bps to 0.54% in 2023, then dropped by -28bps to 0.69% in 2024, then surged by 42bps to 0.4% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.4%, 0.44%, and 0.48% for Q4 2025, Q3 2025, and Q2 2025 respectively.